Alnylam Pharmace. buy Raymond James
Summary
This prediction ended on 29.09.24 with a price of €242.70. The BUY prediction by Raymond_James for Alnylam Pharmace. saw massive gains of 46.20%. Raymond_James has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Raymond_James has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -5.145% | -5.145% | -2.821% |
| iShares Core DAX® | -2.680% | 2.021% | 3.062% |
| iShares Nasdaq 100 | 0.725% | 2.753% | 34.396% |
| iShares Nikkei 225® | -0.725% | 5.698% | 63.753% |
| iShares S&P 500 | 1.166% | 4.063% | 25.141% |
Comments by Raymond_James for this prediction
In the thread Alnylam Pharmace. diskutieren
In the thread Trading Alnylam Pharmace.
Current prediction by Raymond_James for Alnylam Pharmace.
Alnylam Pharmace.
30.07.25
30.07.26
22:25
Stopped prediction by Raymond_James for Alnylam Pharmace.
Alnylam Pharmace.
01.11.24
01.11.25
02.11.25
Alnylam Pharmace.
02.08.24
02.08.25
03.08.25

